深圳医疗器械出口全国居首

Core Insights - Shenzhen has identified biomedicine, high-end medical devices, and the health industry as key sectors within the "20+8" industrial cluster, aiming to create a vibrant and complete ecosystem for pharmaceutical and medical device development [1][2] Industry Growth - The output value of Shenzhen's pharmaceutical and medical device industry is projected to increase from 128 billion yuan in 2020 to 157.6 billion yuan by 2024, with an average annual growth rate of 5.3% [1] - The medical device output is expected to rise from 83.1 billion yuan to 102.8 billion yuan, maintaining its position as the highest in the country [1] - By 2024, the total export value of pharmaceuticals and medical devices is anticipated to reach 41.38 billion yuan, with medical device exports alone accounting for 29.85 billion yuan, also the highest in the nation [1] Development Strategy - Shenzhen plans to establish an industrial development framework consisting of "one corridor, two zones, and three bases," focusing on biomedicine innovation and institutional innovation [2] - The "4+4+N" development strategy will target four emerging sectors, including cell and gene therapy, and will promote key projects in research and development as well as international expansion [2] Specialized Bases - The Pingshan District, recognized as a national-level biomedicine industrial base, has developed a support system with 13 specialized parks covering over 2.79 million square meters, achieving an annual compound growth rate of 39.8% in enterprise numbers [2] - The Guangming District has attracted over 900 medical device companies and over 100 biopharmaceutical companies, with the National Biomanufacturing Industry Innovation Center recently commencing operations to enhance collaborative innovation in the Greater Bay Area [3]